Covington-Led Immunotherapy Co. IFM Lands $56M Financing
Covington & Burling-backed drug researcher IFM Therapeutics said Monday it has closed on a $55.5 million financing round to fund two new subsidiaries and further immunotherapy research for certain inflammatory diseases...To view the full article, register now.
Already a subscriber? Click here to view full article